| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Reviews |
Surgical Service, John D. Dingell VA Medical Center and Departments of Surgery, Anesthesiology, Anatomy, and Cell Biology, Wayne State University Detroit, Michigan
Requests for reprints: Marc D. Basson, Surgical Service, John D. Dingell VA Medical Center, 4646 John R. Street, Detroit, MI 48201-1932. Phone: 313-576-3598; Fax: 313-576-1002; E-mail: marc.basson{at}va.gov.
| Abstract |
|---|
|
|
|---|
| Background |
|---|
|
|
|---|
Although the entire pathway has not yet been elucidated, previous work suggested that the signal events involved occurred primarily within the focal adhesion complex (where FAK and Src bind to the adapter protein paxillin), could be activated by the stimulation of pressure or shear acting on the cell, and could then modulate β1-integrin binding affinity. An intact cytoskeleton seems to be required for FAK activation and the ultimate effect on adhesion (10), so the cytoskeleton may act as a tensegrity style sensor for external forces that activate this pathway. Src activation by extracellular pressure is not affected by cytoskeletal manipulation, however, and what causes Src to be activated when extracellular pressure is increased is as yet unclear.
Elements of the phosphatidylinositol 3-kinase (PI3K) pathway are known to be overexpressed in some malignancies and to influence cell adhesion and motility in other settings. Thus, the search for further elements in the pathway that mediates pressure-stimulated cancer cell adhesion led us to investigate whether signal elements of the PI3K pathway might play a role in mediating the effects of pressure on cancer cell adhesion. Further studies also extended our understanding of these signals away from focal adhesions and into the cytosol.
| Key Findings |
|---|
|
|
|---|
First, PI3K and Akt are also activated by extracellular pressure and required for the stimulation of adhesion by extracellular pressure. The downstream S6 kinase is not involved, however, because rapamycin does not block the effect. This was particularly interesting because rapamycin does block the effect of increased extracellular pressure on macrophage phagocytosis (12). We have previously described other differences between macrophage and cancer cell signaling in response to extracellular pressure.
Second, Src activation seems to be required for PI3K activation, which is in turn required for the activation of FAK and Akt. Indeed, the p85 subunit of PI3K directly associates with FAK in increased proportions in response to increased extracellular pressure, based on coprecipitation studies. This changed our view of the more proximal part of this signal pathway because we had previously postulated that FAK-397 autophosphorylation within focal adhesions was an early event in the pressure-induced pathway, which is required for subsequent FAK-Src interaction and FAK-576/577 phosphorylation by Src (2). In contrast, this observation suggested that FAK-397 phosphorylation in cancer cells responding to extracellular pressure actually requires prior activation of PI3K.
Third, the proportion of cellular phosphorylated (and presumably active) Akt localized within the membrane/cytoskeletal fraction then increases, along with the proportion of cellular phosphorylated (activated) FAK in the same fraction. This is an important finding that may be explained by alternate models. The pressure stimulus may cause one or both of these important kinases to translocate to the membrane either before activation or after activation. Alternatively, the apparent shift in localization of these activated kinases may reflect an inhibition of movement back into the cytosol after activation at the cell membrane. The shifts in Akt and FAK do seem to be linked in some fashion. An Akt inhibitor prevented the shift into the membrane/cytoskeletal fraction of FAK as well as the shift of Akt itself; conversely, FAK seemed to be required for Akt activation because small interfering RNA (siRNA) reduction of FAK blocked Akt activation. A nonphosphorylatable FAK mutant also seemed to shift into the membrane/cytoskeletal fraction with pressure. Although this does not tell us whether FAK activation occurs at the membrane or within the cytosol, it does suggest that the shift in FAK localization in response to extracellular pressure does not require FAK activity. Distinguishing among these competing possibilities will require further study.
However, regardless of the details of these shifts in FAK and Akt activation and localization, the end result of these signals, and our fourth significant finding, is that increased extracellular pressure results in increased association of FAK with β1-integrin heterodimers in a manner sensitive to blockade of Src or PI3K. Such FAK-integrin association could directly modulate integrin binding affinity and explain the ultimate increase in adhesiveness observed in response to increased extracellular pressure. Previous observations confirm that the expression of integrins on the cell surface is not altered in response to extracellular pressure (2).
Fifth and finally, only Akt-1 seems to participate in this pathway. siRNA reduction of Akt-1 blocks the effect of pressure on cell adhesion, but siRNA reduction of Akt-2 does not. This was true both for SW620 colon cancer cells in which Akt-1 predominates and for Caco-2 colon cancer cells in which Akt-1 and Akt-2 expression levels seem to be similar. One caution about these results was that we were only able to achieve a relatively modest 50% to 60% reduction of each Akt isoform by siRNA transfection. Thus, these studies left unanswered the question of whether a more complete reduction in Akt-2 might have been able to inhibit the pressure effect. More recent unpublished observations have further supported our hypothesis that Akt-2 is not involved, however (13).
| Implications |
|---|
|
|
|---|
|
Although this work has focused on mechanotransduced stimuli to date, growth factors or cytokines that act on various elements of this pathway could also modulate cancer cell adhesiveness. Interestingly, the proliferation of colon cancer cells is also stimulated by increased extracellular pressure over hours, albeit via a different signal mechanism (19). These signals might, in the future, offer new targets for intervention to inhibit metastasis, either in the perioperative period or in the setting of unresectable primary tumors. As the proponents of antiangiogenesis have pointed out, an unresectable primary cancer may not be a life-threatening event in many cases if metastasis can be blocked.
The observation of Akt isoform specificity may be interesting in this regard. Although many of the initial studies of Akt function did not distinguish among Akt isoforms, there are actually three Akt isoforms. Akt-1 and Akt-2 are found in all cells, whereas Akt-3 is chiefly found in the brain, heart, and kidney. There is increasing interest in differentiating the functions of the various Akt isoforms. Although opposing roles have been suggested for Akt-2 and Akt-1 in modulating cell motility (20), the current study suggests that Akt-1 is the sole pressure-responsive element that mediates the effect of pressure on cancer cell adhesion. Akt-1 has also this year been reported to selectively regulate integrin activation in endothelial cells and fibroblasts (21).
It is interesting that the stimulation of macrophage phagocytosis by extracellular pressure seems to depend instead on Akt-2 (12). For some other aspects of cell biology, Akt-2 may have other unique functions or the Akt isoforms may have interchangeable functions. The isoform specificity of the pressure-stimulated adhesion effect suggests that Akt-1 may be an interesting target of opportunity on which to act to inhibit cancer cell adhesion with less toxic inhibition of other effects in which Akt-1 may be replaced by Akt-2.
Like any good study, these observations pose more questions than they answer. These include the nature of the proximal mechanosensor by which the cancer cell perceives the physical force; the mechanism responsible for the Akt isoform specificity; whether FAK and Akt are translocating toward the membrane or inhibited from moving away from it and where within the cell their phosphorylation occurs; and the manner in which integrin binding affinity is altered. Such questions await further research, as does the question of whether growth factors or cytokines modulate cancer cell adhesion by acting on this pathway. However, taken together with previous work from our laboratory and others, this study suggests that internal signaling events within tumor cells modulate tumor cell adhesiveness. These signals may prove important targets for therapeutic intervention to inhibit metastasis in the future.
| Acknowledgments |
|---|
Received 8/ 3/07. Accepted 10/ 8/07.
| References |
|---|
|
|
|---|
vβ3. Am J Physiol 2004;287:C1320–7.[CrossRef]This article has been cited by other articles:
![]() |
E. Ciccimaro, S. K. Hanks, and I. A. Blair Quantification of Focal Adhesion Kinase Activation Loop Phosphorylation as a Biomarker of Src Activity Mol. Pharmacol., March 1, 2009; 75(3): 658 - 666. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |